As a Managing Director of Mason Wells Venture Funds, Mr. Broderick is primarily responsible for co-managing the venture investment activities of the firm. In this capacity, Mr. Broderick is responsible for initiating investment opportunities, structuring and negotiating transactions, serving on the Board of Directors of the portfolio companies, working with portfolio company management teams to create shareholder value, and arranging for the orderly disposition of investments at a profit to the fund. Mr. Broderick is a member of the Board of Mason Wells, Inc., and the Management Committee of the firm as well as the Investment Committee for the venture funds.

Mr. Broderick has over 17 years of experience in the biomedical and venture capital industry. Prior to joining Mason Wells in 2000, Mr. Broderick spent 18 years at Mayo Clinic in Rochester, Minnesota were he served as Director of the Office of Technology Commercialization and played a key role in launching Mayo's Venture Fund. His leadership, scientific and business skills helped develop the Mayo Clinic multi-campus technology commercialization organization into one of the most successful and profitable of its kind. He has personally evaluated the commercial potential of hundreds of technologies in virtually every medical specialty. He has been directly responsible for negotiating and consummating over one hundred different commercialization agreements. He has extensive experience with technology evaluation, market assessment, negotiations, academic institution technology transfer and intellectual property management.

While at Mayo Mr. Broderick served on the Board of Directors of Intratherapeutics Inc., CNSoftware, Medintell, Inc., as well as the Operations Committee of Aesgen, Inc. Since joining Mason Wells, Mr. Broderick has served as a member of the Board of Directors for Gala Design, Inc., and Mezzia, Inc., and currently serves on the Boards of OpGen, Inc., Deltanoid Pharmaceuticals, Inc., and ZyStor Therapeutics, Inc. In addition, Mr. Broderick is a co-founder and currently serves as President of the Mid-America Healthcare Investor Network (MHIN), is Vice President of the Wisconsin Venture Capital Association, and is a member of the National Venture Capital Association (NVCA) Board of Directors.

Mr. Broderick received a Bachelors Degree from Iowa State University and an Appointment to the Staff at Mayo Clinic.